Lei Zhang
About Lei Zhang
Lei Zhang is a Director at Sangamo Therapeutics, Inc., where he has worked since 1998, and currently serves as Senior Director of Genome Engineering at Replay since 2022. He holds a PhD in Microbiology from the University of Iowa College of Medicine and previously worked as a Postdoctoral Researcher at the University of California, San Francisco.
Work at Sangamo Therapeutics
Lei Zhang has served as Director at Sangamo Therapeutics, Inc. since 1998. Over the span of 26 years, he has contributed to the company's mission in genomic medicine, focusing on innovative therapies that leverage gene editing technologies. His long tenure reflects a deep commitment to advancing the field of therapeutic development.
Current Role at Replay
Since 2022, Lei Zhang has held the position of Senior Director of Genome Engineering at Replay in La Jolla, San Diego, California. In this role, he oversees projects related to genome editing and engineering, contributing to the company's efforts in developing cutting-edge genetic therapies.
Previous Experience at UCSF
Before joining Sangamo Therapeutics, Lei Zhang worked as a Postdoctoral Researcher at the University of California, San Francisco - School of Medicine from 1995 to 1998. During this period, he engaged in research that laid the groundwork for his future contributions to the field of molecular biology and genetics.
Education and Expertise
Lei Zhang earned his Doctor of Philosophy (PhD) in Microbiology from the University of Iowa College of Medicine, where he studied from 1989 to 1995. His educational background provides a strong foundation in microbiological research, which supports his expertise in genomic medicine and gene editing.